A citation-based method for searching scientific literature

Guillaume Canaud, Frank Bienaimé, Fanny Tabarin, Guillaume Bataillon, Danielle Seilhean, Laure-Hélène Noël, Marie-Agnès Dragon-Durey, Renaud Snanoudj, Gérard Friedlander, Lise Halbwachs-Mecarelli, Christophe Legendre, Fabiola Terzi. N Engl J Med 2014
Times Cited: 169







List of co-cited articles
1033 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
S Miyakis, M D Lockshin, T Atsumi, D W Branch, R L Brey, R Cervera, R H W M Derksen, P G DE Groot, T Koike, P L Meroni,[...]. J Thromb Haemost 2006
64

A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome.
Doruk Erkan, JoAnn Vega, Glendalee Ramón, Elizabeth Kozora, Michael D Lockshin. Arthritis Rheum 2013
150
26

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.
Ricard Cervera, Jean-Charles Piette, Josep Font, Munther A Khamashta, Yehuda Shoenfeld, María Teresa Camps, Soren Jacobsen, Gabriella Lakos, Angela Tincani, Irene Kontopoulou-Griva,[...]. Arthritis Rheum 2002
23

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
Mark A Crowther, Jeff S Ginsberg, Jim Julian, Judah Denburg, Jack Hirsh, James Douketis, Carl Laskin, Paul Fortin, David Anderson, Clive Kearon,[...]. N Engl J Med 2003
540
17

The pathogenesis of the antiphospholipid syndrome.
Bill Giannakopoulos, Steven A Krilis. N Engl J Med 2013
362
15

Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation.
B E Lonze, A A Zachary, C M Magro, N M Desai, B J Orandi, N N Dagher, A L Singer, N Carter-Monroe, S M Nazarian, D L Segev,[...]. Am J Transplant 2014
91
16

Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia.
Silvia S Pierangeli, Guillermina Girardi, Mariano Vega-Ostertag, Xiaowei Liu, Ricardo G Espinola, Jane Salmon. Arthritis Rheum 2005
237
15

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
Hannah Cohen, Beverley J Hunt, Maria Efthymiou, Deepa R J Arachchillage, Ian J Mackie, Simon Clawson, Yvonne Sylvestre, Samuel J Machin, Maria L Bertolaccini, Maria Ruiz-Castellano,[...]. Lancet Haematol 2016
196
15

14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.
Doruk Erkan, Cassyanne L Aguiar, Danieli Andrade, Hannah Cohen, Maria J Cuadrado, Adriana Danowski, Roger A Levy, Thomas L Ortel, Anisur Rahman, Jane E Salmon,[...]. Autoimmun Rev 2014
205
14

Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.
David Fernandez, Eduardo Bonilla, Naureen Mirza, Brian Niland, Andras Perl. Arthritis Rheum 2006
200
14

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
G Finazzi, R Marchioli, V Brancaccio, P Schinco, F Wisloff, J Musial, F Baudo, M Berrettini, S Testa, A D'Angelo,[...]. J Thromb Haemost 2005
339
14


Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.
Zachary Oaks, Thomas Winans, Tiffany Caza, David Fernandez, Yuxin Liu, Steve K Landas, Katalin Banki, Andras Perl. Arthritis Rheumatol 2016
52
25

Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab.
Horacio Berman, Ignasi Rodríguez-Pintó, Ricard Cervera, Nathalie Morel, Nathalie Costedoat-Chalumeau, Doruk Erkan, Yehuda Shoenfeld, Gerard Espinosa. Autoimmun Rev 2013
129
13

Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature.
Laura Andreoli, Cecilia B Chighizola, Alessandra Banzato, Guillermo J Pons-Estel, Guilherme Ramire de Jesus, Doruk Erkan. Arthritis Care Res (Hoboken) 2013
159
13

Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report.
Andreas Kronbichler, Renate Frank, Michael Kirschfink, Ágnes Szilágyi, Dorottya Csuka, Zoltán Prohászka, Peter Schratzberger, Karl Lhotta, Gert Mayer. Medicine (Baltimore) 2014
63
20

A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients.
Doruk Erkan, Rohan Willis, Vijaya L Murthy, Gurjot Basra, JoAnn Vega, Patricia Ruiz-Limón, Ana Laura Carrera, Elizabeth Papalardo, Laura Aline Martínez-Martínez, Emilio B González,[...]. Ann Rheum Dis 2014
74
17

Diagnosis and Management of the Antiphospholipid Syndrome.
David Garcia, Doruk Erkan. N Engl J Med 2018
203
13

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.
Vittorio Pengo, Gentian Denas, Giacomo Zoppellaro, Seena Padayattil Jose, Ariela Hoxha, Amelia Ruffatti, Laura Andreoli, Angela Tincani, Caterina Cenci, Domenico Prisco,[...]. Blood 2018
260
13


Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
R Cervera, R Serrano, G J Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, E de Ramón, V Buonaiuto, S Jacobsen, M M Zeher, T Tarr,[...]. Ann Rheum Dis 2015
287
12

The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features.
Mirhelen M Abreu, Adriana Danowski, Denis G Wahl, Mary-Carmen Amigo, Maria Tektonidou, Marcelo S Pacheco, Norma Fleming, Vinicius Domingues, Savino Sciascia, Julia O Lyra,[...]. Autoimmun Rev 2015
104
12

Eculizumab and renal transplantation in a patient with CAPS.
Bonnie E Lonze, Andrew L Singer, Robert A Montgomery. N Engl J Med 2010
105
12

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines.
R A Asherson, R Cervera, P G de Groot, D Erkan, M C Boffa, J C Piette, M A Khamashta, Y Shoenfeld. Lupus 2003
469
12

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.
Vittorio Pengo, Amelia Ruffatti, Cristina Legnani, Sophie Testa, Tiziana Fierro, Francesco Marongiu, Valeria De Micheli, Paolo Gresele, Marta Tonello, Angelo Ghirarduzzi,[...]. Blood 2011
266
12


Pathogenesis of antiphospholipid syndrome: understanding the antibodies.
Pier Luigi Meroni, M Orietta Borghi, Elena Raschi, Francesco Tedesco. Nat Rev Rheumatol 2011
330
11


Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.
Savino Sciascia, Mary-Carmen Amigo, Dario Roccatello, Munther Khamashta. Nat Rev Rheumatol 2017
64
17

EULAR recommendations for the management of antiphospholipid syndrome in adults.
Maria G Tektonidou, Laura Andreoli, Marteen Limper, Zahir Amoura, Ricard Cervera, Nathalie Costedoat-Chalumeau, Maria Jose Cuadrado, Thomas Dörner, Raquel Ferrer-Oliveras, Karen Hambly,[...]. Ann Rheum Dis 2019
221
11

The intrarenal vascular lesions associated with primary antiphospholipid syndrome.
D Nochy, E Daugas, D Droz, H Beaufils, J P Grünfeld, J C Piette, J Bariety, G Hill. J Am Soc Nephrol 1999
198
10

Current treatment of antiphospholipid syndrome: lights and shadows.
Gerard Espinosa, Ricard Cervera. Nat Rev Rheumatol 2015
68
14

N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
Zhi-Wei Lai, Robert Hanczko, Eduardo Bonilla, Tiffany N Caza, Brandon Clair, Adam Bartos, Gabriella Miklossy, John Jimah, Edward Doherty, Hajra Tily,[...]. Arthritis Rheum 2012
200
10

Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus.
Zhi-Wei Lai, Rebecca Borsuk, Ashwini Shadakshari, Jianghong Yu, Maha Dawood, Ricardo Garcia, Lisa Francis, Hajra Tily, Adam Bartos, Stephen V Faraone,[...]. J Immunol 2013
76
13


Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.
Michael D Lockshin, Mimi Kim, Carl A Laskin, Marta Guerra, D Ware Branch, Joan Merrill, Michelle Petri, T Flint Porter, Lisa Sammaritano, Mary D Stephenson,[...]. Arthritis Rheum 2012
203
10

Guidelines on the investigation and management of antiphospholipid syndrome.
David Keeling, Ian Mackie, Gary W Moore, Ian A Greer, Michael Greaves. Br J Haematol 2012
264
10

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.
Jacob H Rand, Xiao-Xuan Wu, Anthony S Quinn, Anthony W Ashton, Pojen P Chen, James J Hathcock, Harry A M Andree, Douglas J Taatjes. Blood 2010
153
10

Belimumab in primary antiphospholipid syndrome.
A Yazici, B Yazirli, D Erkan. Lupus 2017
21
47

Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients.
A Schmidt-Tanguy, J Voswinkel, D Henrion, J F Subra, L Loufrani, V Rohmer, N Ifrah, C Belizna. J Thromb Haemost 2013
77
12

Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.
Cetin Agar, Gwendolyn M A van Os, Matthias Mörgelin, Richard R Sprenger, J Arnoud Marquart, Rolf T Urbanus, Ronald H W M Derksen, Joost C M Meijers, Philip G de Groot. Blood 2010
170
10

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.
Zhi-Wei Lai, Ryan Kelly, Thomas Winans, Ivan Marchena, Ashwini Shadakshari, Julie Yu, Maha Dawood, Ricardo Garcia, Hajra Tily, Lisa Francis,[...]. Lancet 2018
152
10

Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Maria G Tektonidou, Flora Sotsiou, Lidia Nakopoulou, Panayiotis G Vlachoyiannopoulos, Haralampos M Moutsopoulos. Arthritis Rheum 2004
125
9

Antiphospholipid syndrome nephropathy in systemic lupus erythematosus.
Eric Daugas, Dominique Nochy, Du Le Thi Huong, Pierre Duhaut, Hélène Beaufils, Valérie Caudwell, Jean Bariety, Jean-Charles Piette, Gary Hill. J Am Soc Nephrol 2002
155
9

Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes.
G Canaud, N Kamar, D Anglicheau, L Esposito, M Rabant, L-H Noël, C Guilbeau-Frugier, R Sberro-Soussan, A Del Bello, F Martinez,[...]. Am J Transplant 2013
72
12

Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry.
Ignasi Rodríguez-Pintó, Marta Moitinho, Irene Santacreu, Yehuda Shoenfeld, Doruk Erkan, Gerard Espinosa, Ricard Cervera. Autoimmun Rev 2016
108
9

14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
Ricard Cervera, Ignasi Rodríguez-Pintó, Serena Colafrancesco, Fabrizio Conti, Guido Valesini, Cristina Rosário, Nancy Agmon-Levin, Yehuda Shoenfeld, Claudia Ferrão, Raquel Faria,[...]. Autoimmun Rev 2014
115
9

Pathogenesis and management of antiphospholipid syndrome.
Deepa R J Arachchillage, Mike Laffan. Br J Haematol 2017
39
23

GAPSS: the Global Anti-Phospholipid Syndrome Score.
Savino Sciascia, Giovanni Sanna, Veronica Murru, Dario Roccatello, Munther A Khamashta, Maria Laura Bertolaccini. Rheumatology (Oxford) 2013
137
9

Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome.
Chary López-Pedrera, Patricia Ruiz-Limón, Maria Ángeles Aguirre, Nuria Barbarroja, Carlos Pérez-Sánchez, Paula Buendía, Ines-Carmen Rodriguez-García, Antonio Rodriguez-Ariza, Eduardo Collantes-Estevez, Francisco Velasco,[...]. Ann Rheum Dis 2011
57
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.